Cost is king when it comes to European biosimilars. One issue unites European healthcare payers: the need to provide biosimilars at the most affordable price in cash constrained health services.
Biosimilars: European Payer Perspectives is a thought-provoking and comprehensive report packed with the candid opinions of 15 leading decision makers in pricing, reimbursement, medicines management and pharmacy that present business-critical insights for both biosimilar manufacturers and originator companies.
The speed of development of biosimilars in Europe has been glacial, and the reasons are many and varied. Against a background of vigorous defence by originator companies, awareness of biosimilars, pricing regimes, discounts, biosimilar substitution, clinical confidence – or lack of it - and patient perceptions are just some of the issues which vary widely from country to country. But one thing unites healthcare payers: the need to provide these products at the most affordable price in cash constrained health services.
Biosimilars: European Payer Perspectives gives payer insights on how healthcare payers balance patient safety with clinical anxiety and the need to save money, pricing, how biosimilar manufacturers can find market voice and establish corporate reputation in the field and how much originator companies have to defend their brands.
Key Benefits |
Experts Interviewed |
|
|
FirstView Reports deliver two types of research and analysis: FirstView Advisory and FirstView Trends. FirstView Advisory reports are based on the qualitative insights of 10-15 leading experts, including treating and key opinion leading physicians, payers and industry stakeholders. FirstView Trends reports deliver insights based on quantitative market research which leverages FirstWord’s 1-million strong online physician community. FirstView Advisory and FirstView Trends reports deliver authoritative, actionable insight that can help industry professionals understand future pharma market dynamics and support effective decision making
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors, and your markets. Covering market access, biosimilars, medical affairs, pharma sales and marketing and therapy areas, FirstWord Reports provide timely expert views and intelligence on the challenges facing pharma today.
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved